DrChrono Review 2026: The iPad-native EHR that still does it best.

Why DrChrono is still the iPad pick in 2026

The iPad-EHR category has more entrants than it did a decade ago, but most of them are web apps with an iPad shortcut, not iPad-native experiences. DrChrono is one of the few that started on iPad and still treats it as a first-class surface — handwritten note ingestion, drawing on patient anatomy, on-device photo capture for derm cases, and offline-tolerant charting when you're on a house call without LTE.

In our 90-day test we ran DrChrono on iPad Pro 12.9" and iPhone 15 alongside the web app on a MacBook. The iPad experience consistently outperformed every competitor we tested. The web app, by contrast, feels heavier than the newer challengers like Practice Better or Carepatron — it's functional but not delightful.

What we tested it for

We ran a simulated 4-provider concierge practice for the full 90-day window: weekly patient intake, telehealth visits, in-clinic exams with iPad charting, lab orders via Lab.dna integration, insurance billing through RCM for a subset of patients, and a closed-loop test of the patient portal.

What worked

• iPad charting is exceptional. Apple Pencil support for free-hand notes, in-chart drawing on anatomy diagrams, voice-to-text that's actually accurate on medical vocabulary. The faster you move through visits, the more this matters.
• Marketplace + APIs. 500+ pre-built integrations including Healthie-style nutrition tools, Lab.dna for genetic testing labs, Square for payment processing. The API is well-documented if you have a developer in the org.
• Photo capture in-chart. Snap a photo of a derm lesion or post-op site, it lands in the chart with metadata. Sounds basic, surprisingly few EHRs do it well.
• e-Prescribing + EPCS. DEA-grade controlled substance prescribing is included on Hippocrates+ tiers. Critical for pain management, psychiatry, and most surgical practices.

What didn't

• The web app shows its age. Three-pane layouts, modal-heavy workflows, slower than newer competitors. If you're not primarily on iPad, you may find the web experience frustrating.
• EverHealth cross-sell friction. Since the 2021 acquisition, expect periodic prompts to upsell other EverHealth products (CareCloud, IntakeQ). Manageable, but it's there.
• Support tiers. Basic support is email-only with multi-hour response times. Phone support is a paid add-on. For a sub-$200/mo product this is fine; if you need same-hour response, budget for premium support.
• Pricing opacity. Published pricing is a starting point — actual quotes depend on tier, RCM bundling, and add-ons. Plan to negotiate. Get the quote in writing.

Who DrChrono is for

If any of these describe you, DrChrono should be on your shortlist:

• You see patients away from a desk (house calls, mobile concierge, sports med on the field, derm visits)
• You take a lot of in-visit photos or rely on free-hand anatomical drawings
• You're a small surgical practice and need EPCS-grade e-prescribing without enterprise EHR overhead
• You want a marketplace of integrations rather than building your own
• You're willing to pay 5–10% more for a more polished iPad experience than the cheaper web-first competitors

Who it's not for: primary care practices that live on a desktop, behavioral health practices (SimplePractice or Healthie are better-fit), and dietitians (use Practice Better). If you've never opened an iPad app for work, DrChrono is overkill — pay less for a web-first EHR.

Pricing in 2026 — what to actually expect

DrChrono publishes three tiers (Prometheus, Hippocrates, Apollo Plus) starting at $199/month per provider on the entry tier. The published numbers are starting points. From our quote outreach (anonymous, 4-provider practice), real pricing landed:

• Prometheus: $199/mo per provider, EHR only, no e-Rx of controlled substances. Good for paperless solo practices not billing insurance.
• Hippocrates: $299–$349/mo per provider. Adds EPCS controlled-substance e-Rx, full eligibility checking. The "real" tier for most clinical practices.
• Apollo Plus: $399–$499/mo per provider plus 4–8% RCM. Insurance billing fully managed, dedicated billing support. Worth it above ~$30k/mo collections.
• Add-ons: Telehealth (~$25/mo), premium support (~$99/mo), additional users at staff tier.

Negotiate. Multi-provider practices and 12-month prepay routinely get 10–15% off published quotes. Mention you're evaluating alternatives (mention specific competitors) and pricing flexibility opens up.

DrChrono vs the alternatives

Quick orientation against the 2026 competitive field:

• vs Practice Better: Practice Better is the dietitian/functional-medicine pick with a stronger protocol library. DrChrono is the iPad pick. Different practices, both right answers.
• vs SimplePractice: SimplePractice owns talk therapy and behavioral health. DrChrono is the right answer for mobile / iPad-first specialists. SimplePractice's iPad app is a shortcut to the web app; DrChrono's is native.
• vs athenahealth: athenahealth is enterprise-grade billing and a much bigger payer network. DrChrono is lighter, faster, and cheaper for the small mobile practice. Bigger billing operations = athenahealth.
• vs AdvancedMD: AdvancedMD is the multi-specialty groups pick. DrChrono is the small-team mobile-practice pick. AdvancedMD overscaled for sub-5-provider practices.

The EverHealth question

EverCommerce acquired DrChrono in 2021. Five years in, what does this mean for buyers in 2026?

The positive: sustained product development. DrChrono is no longer a startup running on VC fumes — there's a parent company budget for engineering, security, and compliance. The HIPAA + SOC 2 documentation is enterprise-grade.

The negative: portfolio-style cross-sell. EverHealth owns CareCloud, IntakeQ, and others. Expect occasional prompts to evaluate those products alongside your DrChrono usage. None of it is heavy-handed, but if you're sensitive to platform consolidation as a procurement risk, factor it in.

Net: EverHealth ownership is a non-issue for most buyers. The product hasn't been gutted, support hasn't degraded, and the iPad-first product roadmap continues. We'd buy DrChrono today.

FAQ

Is DrChrono HIPAA-compliant?

Yes. DrChrono will sign a Business Associate Agreement (BAA) on all paid tiers. SOC 2 Type II reports are available on request. We reviewed both during our test.

Can I use DrChrono without an iPad?

Yes, via the web app. But if you're not going to use the iPad as a primary surface, the value proposition shrinks significantly — cheaper web-first competitors will likely serve you better.

Does DrChrono support telehealth?

Yes, with an add-on (~$25/mo). It's serviceable. If telehealth is your dominant modality (>50% of visits), evaluate dedicated telehealth platforms instead.

What about Apollo Plus and full RCM?

The Apollo Plus tier with full Revenue Cycle Management makes sense once your monthly insurance collections cross ~$30,000. Below that, the RCM percentage eats too much margin; do your own billing or use cheaper outsourced billing.

Can I export my data if I leave?

Yes — CCDA export is standard, plus CSV export of demographics and billing. Custom forms and templates require manual recreation in the new EHR. Budget two weeks for migration if switching.

The 90-day call

Buy DrChrono if you're an iPad-first mobile practice (concierge, house-call, sports med, derm, small surgical). The iPad experience is the best in the category and the rest of the product is competent. Pay attention to the tier you actually need — most clinical practices want Hippocrates, not Prometheus, despite the published starting price. Negotiate, and budget for premium support if same-hour response matters to you.

If you're not on iPad most of the day, skip DrChrono and look at Practice Better, SimplePractice, or Carepatron instead. The premium you pay for iPad-first is only worth it if you use the iPad.